Searchable abstracts of presentations at key conferences in endocrinology

ea0028p187 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Not another case of PCOS

Srinivas V , Temple R , Krishnan L , Hadaddin F

A 17 year old girl was referred to us from the gynaecology department with history of primary amenorrhea. She was otherwise well and previous medical history included severe acne requiring referral to ENT, plastic surgery and dermatology services at age 13 and hirsutism for which she had privately funded laser treatment. On examination she had acanthosis nigricans and BMI of 22 but was virilised with clitoromegaly, hypertrophied labia majora and hirsuitism. Pelvic ultrasound r...

ea0015p79 | Clinical practice/governance and case reports | SFEBES2008

Not another case of chronic fatigue syndrome or polycystic ovarian disease

Brahma Anupam , Barakat O , Gorick Sondra , Temple R

Introduction: We present an interesting case of cyclical Cushing’s syndrome who became too unwell to loose her job and confidence as a result of the condition prior to diagnosis of her condition.Case report: A 44-year-old social worker referred by GP in 2007 for investigation of ‘possible hypo- or hyperadrenalism’. She had been diagnosed with polycystic ovary syndrome in 2002 (based on symptoms and ovarian ultrasound) and recently diagnose...

ea0007p308 | Clinical practice | BES2004

A change in role for the endocrine nurse specialist - a survey

Gorick S , Greenwood R , Heyburn P , Sampson M , Temple R

Patient empowerment through informed choice is an important message; consistently reinforced through Government initiatives, Trust directives and our Professional Code of Conduct. Historically the Endocrine Nurse Specialist (ENS) performed the role of clinic nurse during Endocrine Clinic. Recognising this as a waste of specialist expertise and resource; identified drug company funding provided a replacement clinic nurse, liberating the ENS to see patients following their docto...

ea0005p124 | Endocrine Tumours and Neoplasia | BES2003

Acromegaly: A study of epidemiological characteristics and treatment outcomes

Brown C , Sampson M , Greenwood R , Heyburn P , Temple R

Aims: Previous studies of acromegaly have suggested a prevalence of 60 per million and an incidence of 3-4 per million per year. We have performed a population-based survey to ascertain prevalence and incidence of acromegaly, and biochemical outcomes to treatment. Methods: We have reviewed case notes of all patients with acromegaly under the care of the endocrine unit (referral population of 700,000). Growth hormone (GH) and IGF-1 levels at follow-up were examined. Results: Th...